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Introduction: In addition to the well-known short noncoding RNAs such as microRNAs (miRNAs), increasing
evidence suggests that long noncoding RNAs (lncRNAs) act as key regulators in a wide aspect of biologic processes.
Dysregulated expression of lncRNAs has been demonstrated being implicated in a variety of human diseases.
However, little is known regarding the role of lncRNAs with regards to intervertebral disc degeneration (IDD). In the
present study we aimed to determine whether lncRNAs are differentially expressed in IDD.
Methods: An lncRNA-mRNA microarray analysis of human nucleus pulposus (NP) was employed. Bioinformatics
prediction was also applied to delineate the functional roles of the differentially expressed lncRNAs. Several lncRNAs
and mRNAs were chosen for quantitative real-time PCR (qRT-PCR) validation.
Results: Microarray data profiling indicated that 116 lncRNAs (67 up and 49 down) and 260 mRNAs were highly
differentially expressed with an absolute fold change greater than ten. Moreover, 1,052 lncRNAs and 1,314 mRNAs
were differentially expressed in the same direction in at least four of the five degenerative samples with fold
change greater than two. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis for the differentially
expressed mRNAs indicated a number of pathways, such as extracellular matrix (ECM)-receptor interaction. A
coding-noncoding gene co-expression (CNC) network was constructed for the ten most significantly changed
lncRNAs. Annotation terms of the coexpressed mRNAs were related to several known degenerative alterations, such
as chondrocyte differentiation. Moreover, lncRNAs belonging to a particular subgroup were identified. Functional
annotation for the corresponding nearby coding genes showed that these lncRNAs were mainly associated with
cell migration and phosphorylation. Interestingly, we found that Fas-associated protein factor-1 (FAF1), which
potentiates the Fas-mediated apoptosis and its nearby enhancer-like lncRNA RP11-296A18.3, were highly expressed
in the degenerative discs. Subsequent qRT-PCR results confirmed the changes.
Conclusions: This is the first study to demonstrate that aberrantly expressed lncRNAs play a role in the
development of IDD. Our study noted that up-regulated RP11-296A18.3 highly likely induced the over-expression of
FAF1, which eventually promoted the aberrant apoptosis of disc cells. Such findings further broaden the understanding
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Table 1 Study-related specimen information
Sample number Disc level Pfirrmann grade Gender Age
Deg -1 L4 to L5 5 F 32
Deg-2 L3 to L4 5 M 38
Deg-3 L3 to L4 4 M 42
Deg-4 L5 to S1 5 M 45
Deg-5 L4 to L5 4 F 27
Nor -1 L3 to L4 1 M 33
Nor-2 L3 to L4 1 M 35
Nor-3 L4 to L5 1 M 41
Nor-4 L5 to S1 1 F 43
Nor-5 L4 to L5 1 M 52
Deg, degenerative sample; Nor, normal sample. L, lumbar; S, sacral.
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Low back pain is a global burden, affecting the quality of
life and resulting in serious socioeconomic consequences
[1,2]. The main cause of low back pain is intervertebral disc
degeneration (IDD) (Online Mendelian Inheritance in Man
(OMIM) # 603932) [3]. Numerous studies indicate that a
variety of cellular events are disturbed in the progression of
IDD, ranging from matrix synthesis to cytokine expression
[4]. Underlying these alterations there is the dysregulated
gene expression of particular molecules. Large-scale gene
expression studies have unveiled that a great number of
coding genes are differentially expressed in IDD, parts of
which were demonstrated as playing significant roles in
IDD [5,6]. With the progress of genetic and proteomic
tools, our understanding of gene dysregulation in IDD has
been expanded greatly. Several treatment strategies target-
ing dysregulated genes have been proposed in IDD animal
models with encouraging results [7,8]. However, dysregula-
tion of gene expression is a very complex process. Previous
studies suggest that alterations of several regulatory factors
at different levels result in the aforementioned eventual
gene dysregulation [9]. Among these factors, aberrantly
expressed regulatory noncoding RNAs have attracted con-
siderable attention in recent years.
Noncoding RNAs are a diverse group of transcriptional
outputs of the mammalian genome without protein-coding
function. A growing body of evidence suggests that non-
coding RNAs participate in a multitude of processes coor-
dinating gene expression [10]. There are two major groups
of noncoding RNAs, short noncoding RNA, which has less
than 200 nucleotides, and large noncoding RNA (lncRNA),
which contain over 200 nucleotides, some more over
100,000 nucleotides [11]. miRNAs, the well-understood
short noncoding RNAs, function by binding to the 3'-
untranslated region of their target mRNAs, triggering
either translation inhibition or mRNA degradation [12].
miRNAs have different expressions in numerous diseases
[13,14]. In fact, miRNAs have been noted to play a role in
IDD development. We have previously addressed the
expression profiles of miRNAs in IDD [15].
In the past decade, growing numbers of lncRNAs have
been recognized and shown to function in virtually every
aspect of human biology [16], including chromosomal
dosage compensation, control of imprinting, chromatin
modification, chromatin structure, transcription, splicing,
translation, cellular differentiation, integrity of cellular
structures, cell cycle regulation, intracellular trafficking,
reprogramming of stem cells and heat shock response
[17]. Multiple lines of evidence also strongly link mutation
and dysregulation of lncRNAs to a range of human
diseases, including neurodegeneration and cancer [18].
However, to date, there have been no studies addressing
the expression profiles of lncRNAs in IDD. As such, in this
study, we performed a lncRNA-mRNA microarray analysisto identify the expression profiles of lncRNAs in the nu-
cleus pulposus (NP) in IDD. A series of bioinformatics
prediction methods were applied for the function annota-
tion of the differentially expressed lncRNAs.
Methods
Sample collection
The study procedures were approved by the Ethics Review
Board of Xijing Hospital (number 20111103-7) and the
study has been carried out in accordance with the Declar-
ation of Helsinki (2008) of the World Medical Association.
Degenerative NP samples were derived from patients with
IDD. Patients with IDD combined with degenerative spinal
stenosis, idiopathic scoliosis, tumors, infections or previous
lumbar disc surgery were excluded from this study. Non-
degenerative specimens were obtained from cadaveric do-
nors. All patients or relatives of the cadaveric donors were
fully informed of the aim and protocols of the study, and
agreed to participate in the study. Subsequently, written in-
formed consent was obtained. The degenerative condition
of IDD was evaluated on magnetic resonance imaging
(MRI) (for the cadavers MRI data were collected from re-
cords) according to the Pfirrmann’s grading system [19].
All specimens were obtained from the lumbar spine
(Table 1). Samples obtained from graded as 1 from cada-
veric donors were classified as the normal group, samples
graded as 4 or 5 from patients were included in the IDD
group. All the specimens were collected within 3 hours
after disc excision (for discs from patients with IDD) or
death (for discs from cadaveric donors), following rinsing
with phosphate-buffered saline, the NP tissue was carefully
collected under a stereoscopic microscope. Five degenera-
tive and five normal samples were obtained from five
patients and five cadaveric donors respectively.
RNA isolation and quality control assay
Total RNA was extracted from homogenized samples with
TRIzol® reagent (Invitrogen Life Technologies, San Diego,
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the RNA was cleaned with a RNasey Mini Kit (Qiagen,
Germantown, MD, USA). RNA quantity was measured
using the NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE, USA). RNA
integrity and gDNA contamination were assessed by
denaturing agarose gel electrophoresis.
Microarray analysis
The microarray used in the current study was Arraystar
Human LncRNA Array v2.0 (Arraystar, Rockville, MD,
USA), which contains 33045 lncRNAs and 30215 protein-
coding transcripts. The lncRNAs were collected from
several authoritative data sources, including RefSeq, UCSC
Known genes, Ensembl and related literature. The mRNAs
were obtained from RefSeq (March 2011). Each transcript
is represented by a specific exon or splice junction probe
which can identify individual transcripts accurately. Posi-
tive probes for housekeeping genes and negative probes
were also printed onto the array for hybridization quality
control.
The microarray analysis was performed according to
the standard procedure. Briefly, mRNA was purified from
total RNA after removal of rRNA using mRNA-ONLY™
Eukaryotic mRNA Isolation Kit (Epicentre, Madison, WI,
USA). Subsequently, each sample was amplified and tran-
scribed into fluorescent cRNA along the entire length of
the transcripts without 3’ bias, utilizing a random priming
method. The labeled cRNAs were purified by RNeasy Mini
Kit (Qiagen). The concentration and specific activity of
the labeled cRNAs (pmol Cy3/μg cRNA) were measured
by NanoDrop ND-1000. One μg of each labeled cRNA
was fragmented by adding 5 μl 10 × blocking agent and
1 μl of 25 × fragmentation buffer, then the mixture was
heated at 60°C for 30 minutes; finally, 25 μl 2 × GE
hybridization buffer was added to dilute the labeled cRNA.
Fifty μl of hybridization solution was dispensed into the
gasket slide and assembled to the lncRNA expression
microarray slide. The slides were incubated for 17 hours
at 65°C in an Agilent hybridization oven (Agilent Tech-
nologies, Santa Clara, CA, USA). The hybridized arrays
were washed, fixed and scanned with the Agilent DNA
Microarray Scanner (Agilent Technologies).
Data analysis
Agilent Feature Extraction software (version 11.0.1.1)
(Agilent Technologies) was used to analyze acquired array
images. Quantile normalization and subsequent data pro-
cessing were performed with the Gene Spring GX v11.5.1
software package (Agilent Technologies). After quantile
normalization of the raw data, lncRNAs and mRNAs that
at least 5 out of 10 samples have flags in Present or
Marginal (All Targets Value) were chosen for further data
analysis. The normalized intensity for each lncRNA andmRNA was presented as a log2-transformed pattern. The
microarray data have been deposited in the National Center
for Biotechnology Information Gene Expression Omnibus
(GEO) [GSE56081: GEO]. Differentially expressed lncRNAs
and mRNAs between two groups were identified through
fold-change filtering and Student’s t-test. Multiple testing
correction was performed by calculating the Benjamini-
Hochberg false discovery rate (FDR). Fold-change greater
than two, a P-value <0.05 (two-tailed) and an FDR <0.05
were considered the criteria for differential expression. A
positive fold-change value indicates upregulation and a
negative fold-change value indicates downregulation.
lncRNA classification and subgroup analysis
The lncRNAs were classified into different subgroups and
analyzed according to their various interaction mechanisms
with mRNAs. Human homeobox transcription factors
(HOX) cluster mRNAs and lncRNAs were screened based
on the previous study [20]. lncRNAs with enhancer-like
function were identified using GENCODE annotation [21]
of the human genes [22]. The consideration of selection of
lncRNAs with enhancer-like function excluded transcripts
mapping to the exons and introns of annotated protein
coding genes, the natural antisense transcripts, overlap-
ping the protein coding genes and all known transcripts.
The large intervening noncoding RNAs (lincRNAs) were
also identified according to John Rinn's papers [23,24].
Functional annotation of the differentially expressed mRNAs
Kyoto Encyclopedia of Genes and Genomes (KEGG) en-
richment analysis was used to analyze the biological path-
ways, involving the differentially expressed mRNAs. The
Database for Annotation, Visualization and Integrated
Discovery (DAVID) (version 6.7) was applied to investigate
the functional enrichment condition of the differentially
expressed mRNAs, which were upregulated or downregu-
lated shared by four of the five degenerative samples or in
all degenerative samples with the normalized intensities
altered more than 2-fold compared with the normal sam-
ples. We also used the DAVID for functional annotation
of the nearby coding genes of the differentially expressed
Rinn’s lincRNAs and enhancer-like lncRNAs. The default
annotation category and the high-classification stringency
settings were selected. Functional annotation clusters with
an enrichment score >1.3 were considered significant [25].
Quantitative real-time PCR (qRT-PCR) assay
Although microarray is an excellent tool for target-gene
screening discovery, its credibility is limited by the incon-
sistency of the technique, weak sensitivity and specificity.
Thus, candidate target genes are required to be validated
with highly reliable biotechniques, such as qRT-PCR [26].
Four randomly selected differentially expressed lncRNAs
lincRNA-SLC20A1-1 [lincRNA:BI522654], RP11-296A18.3
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ENST00000492365], lincRNA-BTG2 [lincRNA:X75546]
and two differentially expressed mRNAs CASP8 [RefSeq_-
coding:NM_001080124], FAF1 [RefSeq_coding:NM_007051]
were chosen to validate the gene chip results using qRT-
PCR. The lncRNAs, mRNAs and specific primers are noted
in Table 2. The qRT-PCR analysis was performed according
to the following procedure. Briefly, total RNA was extracted
from NP tissue using TRIzol® reagent (Invitrogen). Then
cDNAs were synthesized from total RNA using Super
Script™ III Reverse Transcriptase (Invitrogen) on Gene
Amp® PCR System 9700 (Applied Biosystems, Foster City,
CA, USA). qRT-PCR was performed on a ViiA™ 7 Real-
time PCR System (Applied Biosystems) with a total
reaction volume of 10 μl, including 5 μl 2X PCR master
mix (Superarray Bioscience Corporation, Frederick,
MD, USA), 0.5 μl of PCR forward primer (10 μM),
0.5 μl of PCR reverse primer (10 μM), 2 μl of cDNA and
2 μl of double-distilled water. The thermal cycling
conditions were as follows: initial denaturation at 95°C
for 10 minutes, followed by 40 cycles of 10 seconds of
denaturing at 95°C, 60 seconds of annealing at 60°C and
15 seconds of extension at 72°C. Each qRT-PCR reac-
tion was done with a technical triplicate. The expression
levels of the target lncRNAs and mRNAs were normal-
ized to that of glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) in cDNA samples.
Co-expression network construction
A coding-noncoding gene co-expression (CNC) network
was constructed based on the Pearson correlation calcula-
tion for the normalized signal intensity of differentially
expressed lncRNAs and mRNAs. The top five upregulatedTable 2 lncRNAs and mRNAs for qRT-PCR validation and
the primer sequences














R GAGTGGGTGTCGCTGTTGA(RP11-475I24.4 [Ensembl:ENST00000461676], CTB-28 J9.3
[Ensembl:ENST00000514459], AC005077.14 [Ensembl:
ENST00000421546], [misc_RNA:AK023939] and [mis-
c_RNA:G43223]) and top five downregulated lncRNAs
(HOTAIR [RefSeq_NR:NR_003716], nc-HOXA13-96
[HOX cluster:nc-HOXA13-96-], AC131180.3 [Ensembl:
ENST00000451959], [misc_RNA:AK096112] and nc-
HOXD1-48 [HOX cluster:nc-HOXD1-48+]) were selected
as the sources of the network. The significant correlated
mRNAs were chosen as the targets to build the network
with an absolute value of the Pearson correlation coeffi-
cient >0.99 using the program Cytoscape (version 3.0.1).
For coding genes with several transcripts, the median
value of different transcripts was taken as the value of the
genes expression. Yellow round rectangle nodes represent
the upregulated lncRNAs in the network, while the blue
nodes represent the downregulated lncRNAs. Pink round
nodes represent the upregulated mRNAs, while the green
round nodes represent the downregulated mRNAs. Solid
lines indicate positive correlation, whereas dashed lines
indicate negative correlation. Correlation degrees for each
pair of nodes were weighted and delineated by the length
of the lines. KEGG enrichment analysis and Gene Ontology
(GO) analysis were used to annotate the function roles of
mRNAs significantly correlated with the aforementioned
lncRNAs.
Statistical analysis
Statistical analysis was performed using SPSS 17.0 software
package. Student’s t-test was applied to analyze the expres-
sion difference of the particular lncRNAs or mRNAs in
microarray and PCR analysis. Moreover, the Benjamini-
Hochberg FDR (the FDR cutoff was 0.05) was used for
multiple-testing correction. A P-value <0.05 (two tailed)
was considered statistically significant.
Results
Microarray data
Results of the quality control assay showed that total
RNAs extracted from the samples qualified for subsequent
experiments. The hierarchical clustering was performed
based on the lncRNA expression values in the microarray
(Figure 1). Microarray data indicated that a total of 1,806
lncRNAs and 2,307 mRNAs were significantly differen-
tially expressed in IDD compared with the control group.
Among them, 1,357 lncRNAs were upregulated with 449
lncRNAs downregulated and 1,694 mRNAs were upregu-
lated with 613 mRNAs downregulated. The top 10 up-
regulated and top 10 downregulated lncRNAs are listed in
Table 3. In addition, 116 lncRNAs (67 upregulated and 49
downregulated) and 260 mRNAs (137 upregulated and
123 downregulated) were highly differentially expressed
with an absolute fold-change >10 (see Additional file 1).
Furthermore, 237 lncRNAs were upregulated shared by
Figure 1 Hierarchical clustering dendrogram and heat map. Hierarchical clustering based on lncRNA expression value showed a
distinguishable gene expression profiling among samples. Green strip indicates high relative expression and red strip indicates low relative
expression. N1 represents normal sample 1, D1 represents degenerative sample 1, and so on.
Wan et al. Arthritis Research & Therapy 2014, 16:465 Page 5 of 11
http://arthritis-research.com/content/16/5/465four of the five degenerative samples with the normalized
intensities altered more than 2-fold compared with all the
normal specimens (see Additional file 2). On the other
hand, 629 lncRNAs were upregulated in all degenerative
specimens with a fold-change >2 compared with all the
control samples (see Additional file 2). Among the differ-
entially downregulated lncRNAs, 42 lncRNAs were down-
regulated in four of the five degenerative samples; whereas
144 lncRNAs were downregulated in all degenerative sam-
ples (see Additional file 2). There were 323 over-expressed
and 75 downregulated mRNAs in four of the five degen-
erative samples, whereas there were 670 over-expressed
mRNAs and 246 downregulated mRNAs in all degenera-
tive samples with a fold change >2 compared with all the
normal samples (see Additional file 2).
lncRNA classification and subgroups
In 2007, Rinn et al. described 407 HOX transcripts in
the four HOX loci, including 101 exons, 75 introns and
231 intergenic transcripts [20]. As a family of highly
conserved transcription factors, the HOX transcripts
were originally discovered to regulate body develop-
ment. The mutation and dysregulation of HOX tran-
scripts pertain to a number of diseases, ranging from
limb malformation to hematologic malignancies [27,28].In the current study, we detected 160 HOX coding tran-
scripts in all samples, 16 of which were differentially
expressed in IDD compared with the control group
(fold-change >2, P <0.05, FDR <0.05). Additionally, 292
noncoding transcripts were detected with 29 differentially
expressed transcripts in IDD (fold-change >2, P <0.05,
FDR <0.05). Both the differentially expressed coding and
noncoding transcripts in degenerative samples are shown
in Additional file 3.
Ørom and coworkers identified a set of lncRNAs
characterized with enhancer-like function, which are
expressed in multiple cell lines [22]. By filtering the
array data, we detected 951 enhancer-like lncRNAs in
all specimens. We noted that 76 lncRNAs were differen-
tially expressed in IDD compared with control (fold-
change >2, P <0.05, FDR <0.05). Moreover, there were
25 differentially expressed lncRNAs with differentially
expressed nearby coding genes (distance <300 kb) (see
Additional file 3). In these 25 pairs of differentially
expressed lncRNAs and nearby coding genes, 18 pairs
were dysregulated in a same direction (up or down).
Thousands of lincRNAs are encoded in the mam-
malian genome with highly conserved features across
mammals [23,24]. These lincRNAs are involved in diverse
biological processes, including cell-cycle regulation, immune
Table 3 The top 10 upregulated and downregulated
lncRNAs detected by microarray analysis in the
degenerative group
Sequence name Source database Fold-change P-value
Upregulated lncRNAs
ENST00000461676 Ensembl 135.56903 6.51E-07
ENST00000514459 Ensembl 97.71137 1.78E-05
ENST00000421546 Ensembl 73.82017 1.19E-05
AK023939 misc_RNA 52.0571 6.00E-07
G43223 misc_RNA 38.324024 1.47E-06
ENST00000446763 Ensembl 36.52328 6.72E-04
ENST00000432925 Ensembl 34.249966 1.68E-03
uc003mjv.3 UCSC_knowngene 33.52595 6.32E-05
U94385 RNAdb 31.505856 3.28E-04
chr8:87319334-87331334+ lincRNA 29.106977 6.94E-05
Downregulated lncRNAs
NR_003716 RefSeq_NR 148.53123 7.83E-05
nc-HOXA13-96- HOX cluster 111.87458 1.68E-06
ENST00000451959 Ensembl 96.609 2.52E-05
AK096112 misc_RNA 95.62264 8.97E-05
nc-HOXD1-48+ HOX cluster 89.8041 1.86E-05
BG897081 lincRNA 82.24899 4.28E-06
uc003tjk.2 UCSC_knowngene 77.483154 2.58E-06
NR_027154 RefSeq_NR 76.309654 3.74E-07
BX646285 lincRNA 74.3615 9.86E-05
AK125976 misc_RNA 72.67137 1.42E-04
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ing data based on Rinn’s lincRNAs indicated that 190
lincRNAs were differentially expressed in IDD within 2,043
detected lincRNAs (fold-change >2, P <0.05, FDR <0.05)
(see Additional file 3). It is noteworthy that 63 differen-
tially expressed lincRNAs had differentially expressed
nearby coding genes (distance <300 kb) (see Additional
file 3).Functional annotation results of the differentially
expressed mRNAs
Based on the latest version of the KEGG database, we
employed KEGG pathway analysis for differentially expressed
mRNAs (separately for upregulated mRNAs and down-
regulated mRNAs). Accordingly, we revealed the biological
pathways with significant enrichment of differentially
expressed mRNAs. Each P-value denoted the significance of
the corresponding pathway. The lower the P-value, the more
significant the pathway was (the P-value cutoff was 0.05).
Enrichment-score values were also calculated, representing
the enrichment importance of pathway IDs. The values
equaled -log10 (P-values). The greater the enrichment score,the more significant the pathway was. The results of
the KEGG pathway analysis were shown in Figure 2 and
Additional file 4.
The DAVID functional annotation clustering was ap-
plied to investigate the functional enrichment of upregu-
lated or downregulated mRNAs altered more than 2-fold
in at least four of the five degenerative samples. The
most significant functional clusters are listed in Table 4
and Additional file 4. Table 5 and Additional file 4
summarize the results of DAVID functional annotation
clustering for the neighboring coding genes of differen-
tially expressed Rinn lincRNAs and enhancer-like
lncRNAs. Enrichment-score values indicated the enrich-
ment importance of clusters. The greater the enrichment
score, the more significant the cluster was.
qRT-PCR validation
To validate the microarray results, four lncRNAs and two
mRNAs were selected for the qRT-PCR analysis in 12
human lumbar disc NP samples (6 degenerative and 6
normal samples: detailed sample information is not
provided in the paper). The expression of lincRNA-
SLC20A1-1 (P <0.05), RP11-296A18.3 (P <0.05), KB-
1683C8.1 (P <0.05), CASP8 (P <0.05) and FAF1 (P <0.05)
were significantly increased in degenerative discs com-
pared with the normal discs, whereas the expression of
lincRNA-BTG2 (P <0.05) was significantly decreased
(Figure 3). The fold-changes of the normalized inten-
sities were 5.99, 3.21, 2.82, 0.168, 2.42 and 2.17, respect-
ively, for the four lncRNAs (lincRNA-SLC20A1-1,
RP11-296A18.3, KB-1683C8.1 and lincRNA-BTG2) and
two mRNAs (CASP8 and FAF1) in the gene chip ana-
lysis between the IDD and the normal group. For the
expression levels in qRT-PCR analysis, the fold-changes
were 2.83, 2.50, 2.08, 0.46, 1.84 and 1.68 respectively.
The data for qRT-PCR were consistent with the micro-
array results.
CNC network
A CNC network was built for the ten differentially
expressed lncRNAs and hundreds of differentially
expressed mRNAs based on the degree of correlation
(see Additional file 5). There were 197 nodes in the
network, comprising 10 lncRNAs nodes and 187 mRNAs
nodes. These 197 RNAs combined into 673 pairs of
co-expressed lncRNAs and mRNAs (see Additional file 6).
KEGG biological pathway analysis indicated that 187
mRNAs were mainly pertinent to the pathways of ribo-
some and antigen processing and presentation (see
Additional file 6). GO terms with regard to these mRNAs
are also listed in Additional file 6. Importantly, GO terms
of remarkable research interest were found in the list,
encompassing translational elongation, negative regu-
lation of cell differentiation, cartilage development,
Figure 2 Results of the KEGG pathway analysis for the differentially expressed mRNAs. (a) The 10 most significant KEGG pathways of the
upregulated mRNAs. (b) The 10 significant KEGG pathways of the downregulated mRNAs. The length of the column in the figure represents the
enrichment score of the each pathway. ECM, extracellular matrix; TGF, transforming growth factor.






Most significant functional clusters for the mRNAs upregulated in at least four of the five degenerative samples
1 Nucleosome core, protein-DNA complex, chromatin assembly, et cetera 3.91
2 Glycosaminoglycan binding, polysaccharide binding, pattern binding, et cetera 3.89
3 Ribosome, translational elongation, cytosolic ribosome 3.63
4 Histone H2A 2.78
5 Basic-leucine zipper domain, DNA-binding region: basic motif 2.58
Most significant functional clusters for the mRNAs downregulated in at least four of the five degenerative samples
1 Negative regulation of gene expression, negative regulation of transcription, negative regulation of nucleobase,
nucleoside, nucleotide and nucleic acid metabolic process, et cetera
1.60
2 Cytosolic ribosome, ribosome, ribosomal subunit, et cetera 1.51
3 Phosphoglycerate mutase, Tele-phosphohistidine intermediate, Phosphoglycerate mutase, et cetera 1.49
4 Purine nucleotide biosynthetic process, purine nucleotide metabolic process, nucleotide biosynthetic process, et
cetera
1.44
5 Proteasomal ubiquitin-dependent protein catabolic process, proteasomal protein catabolic process, ubiquitin-
dependent protein catabolic process, et cetera
1.40
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1 Phosphorylation, phosphorus metabolic process, phosphate metabolic process 1.79
2 Regulation of phosphorylation, regulation of phosphorus metabolic process, regulation of phosphate
metabolic process
1.76
3 Cellular respiration, mitochondrial ATP synthesis coupled electron transport, ATP synthesis coupled electron
transport, et cetera
1.59
4 Regulation of cell migration, regulation of locomotion, regulation of cell motion 1.33
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differentiation, collagen fibril organization, posttran-
scriptional regulation of gene expression, regulation of
apoptosis and proteoglycan metabolic process. One
CNC network was constructed for each of the afore-
mentioned 10 lncRNAs (Additional file 7).
Discussion
In the current study, by means of microarray analysis and
in-depth data profiling we found that a large amount ofFigure 3 QRT-PCR confirmation results of the four lncRNAs and two m
1683C8.1, lincRNA-BTG2 and two mRNAs CASP8, FAF1 were chosen for the
columns in the figure represents the lncRNA expression level relative to gly
deviation. Normal represents the normal disc group; Degenerated represenlncRNAs and mRNAs were differentially expressed in de-
generative discs. Succeeding qRT-PCR confirmation re-
sults of the four randomly selected lncRNAs matched well
with the microarray data, demonstrating high credibility
for the lncRNAs microarray analysis.
Similar to our findings, previous microarray studies on
gene expression in degenerative discs reveal that many
mRNAs are aberrantly expressed in the degeneration
process [6]. Functional annotation for these differentially
expressed mRNAs may provide a precise perspective toRNAs. The four lncRNAs lincRNA-SLC20A1-1, RP11-296A18.3, KB-
validation of the gene chip results using qRT-PCR. The height of the
ceraldehyde-3-phosphate dehydrogenase; the bars represent standard
ts the degenerated disc group.*P <0.05 versus the normal group.
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of the mRNAs involved in IDD. Based on such a consid-
eration, several bioinformatics methods such as KEGG
pathway analysis were employed in our study. KEGG
pathway analysis showed that not only the upregulated
mRNAs were involved in the biological pathways, in-
cluding focal adhesion, extracellular matrix (ECM)-re-
ceptor interaction, adherens junction and ubiquitin-
mediated proteolysis, but the downregulated mRNAs
also participated in the four pathways. This indicates
that biological processes and the consequence of the ac-
tivity of the aforementioned four pathways in IDD are
significantly different from those in normal discs. In
addition pathway terms, such as other glycan degrad-
ation, antigen processing and presentation, and trans-
forming growth factor-beta signaling pathways, were
observed in the results of the KEGG pathways analysis
for the upregulated mRNAs. Breakdown of the immune-
privilege status of the discs has been noted as an essen-
tial pathogenesis factor contributing to the IDD [29].
Once the components of discs are exposed to the im-
mune system, such materials will be recognized as for-
eign bodies and processed by the antigen presenting
cells (APCs) and presented to the T lymphocytes, indu-
cing autoimmune attack on the disc. Increased expres-
sion of several genes, for example, CD74 and KIR2DS2
were observed in the pathway of antigen processing and
presentation. CD74 plays a critical role in antigen pres-
entation from APCs to CD4-positive T lymphocytes by
influencing the expression and antigen peptide loading
of the major histocompatability complex (MHC) class II
molecules on APCs [30]. Moreover, subsequent studies
indicate that CD74 is involved in the release of inflamma-
tory cytokines induced by macrophage migration inhibi-
tory factor and associated with the Modic changes of
cartilage endplate degeneration in IDD [31]. KIR2DS2
plays a supporting role in natural killer cell-mediated cyto-
toxicity. Meanwhile, the increased expression of KIR2DS2
can reduce the threshold of T-cell activation and result in
an increased risk of rheumatoid arthritis [32].
Further data analyses showed in total about half of the
mRNAs (1,314 mRNAs) were upregulated (993, with 323
in four of the five degenerative samples, and 670 in all de-
generative samples) or downregulated (321, with 75 in
four of the five degenerative samples, and 246 in all degen-
erative samples) in at least four of the five degenerative
samples with normalized intensities, altering more than 2-
fold compared with the non-degenerative samples. DAVID
functional annotation clustering was employed for the
functional annotation of the mRNAs. Among the clusters,
terms of membrane-bound vesicles were also noted, which
pertain to upregulated genes in IDD development [33].
Interestingly, several other clusters were observed in our
study, including apoptosis and negative regulation ofgene expression. These pathologic findings are consist-
ent with previous studies in IDD [34,35].
In addition to the numerous differentially expressed
mRNAs, thousands of lncRNAs were detected and differen-
tially expressed in the degenerative samples. The variation
of lncRNA expression in the degenerative intervertebral
discs implicates that lncRNAs may play a crucial role in the
onset and development of IDD. Further analysis revealed
that 866 (237 in four of the five degenerative samples, 629
in all degenerative samples) and 186 lncRNAs (42 in four
of the five degenerative samples, 144 in all degenerative
samples) were upregulated and downregulated in at least
four of the five degenerative samples, respectively, with
normalized intensities altered more than 2-fold com-
pared with the normal samples. These portions of
lncRNAs were highly likely relevant to the occurence
and progression of IDD. Moreover, these lncRNAs ac-
count for 64% and 41% of the upregulated and down-
regulated lncRNAs, respectively.
A CNC network was constructed based on the Pearson
correlation analysis data of ten differentially expressed
lncRNAs and hundreds of differentially expressed mRNAs.
The ten lncRNAs comprised the top five upregulated and
top five downregulated lncRNAs. GO analysis for the co-
expressed mRNAs indicates that lncRNAs play important
roles in several pathological alterations of IDD, including
matrix remodeling and NP cell apoptosis. Details of the
roles of lncRNAs and of how lncRNAs function deserve
further study.
Certain lncRNAs with particular features can be di-
vided into several subgroups, such as Rinn lincRNAs
and enhancer-like lncRNAs. It has been shown that the
transcription of these lncRNAs can affect the expression
of their nearby coding genes [22]. Dysregulated lncRNAs
are closely linked with a variety of diseases [36,37]. The
DAVID functional annotation clustering indicates that
these lncRNAs are closely related to various biological
processes, such as cell migration and phosphorylation.
As induced by Fas and Fas ligand (FasL) interaction,
apoptosis of disc cells plays an important role in IDD
[38,39]. In accordance with previously reported upregulated
Fas and FasL [40,41], our study indicates that FAF1 was
highly expressed in degenerative discs. Subsequent qRT-
PCR results confirmed the expression changes. FAF1 is a
multi-domain protein as a member of the Fas death-
inducing signaling complex [42]. Over-expression of FAF1
can significantly potentiate Fas-mediated apoptosis and in-
hibit the degradation of ubiquitinated proteins, resulting in
increased cell death [43,44]. Corresponding to the upregu-
lated FAF1, we also found that the nearby enhancer-like
lncRNA, RP11-296A18.3, was significantly increased in
degenerative discs compared with the normal discs.
Enhancer-like lncRNAs can activate the proximal promoter
and stimulate transcription of their nearby coding genes.
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neighboring protein-coding genes [22]. Whether upregu-
lated RP11-296A18.3 causes the over-expression of its
nearby gene FAF1 and is eventually involved in the aberrant
apoptosis of NP cells in degeneration represents an interest-
ing issue that deserves to be further explored.
There are several limitations in the current study. For
one, the scarce number of samples included in the micro-
array analysis may limit the validity of the array results.
Moreover, limited by the research approaches, we merely
predicted the function of the differentially expressed
lncRNAs, but could not confirm and illustrate the detailed
functional roles of these lncRNAs. Function of the identi-
fied lncRNAs can be investigated by over-expression and
RNA interference approaches in vitro and in vivo [45].
Selectively upregulating or downregulating the certain
lncRNA expression in cell cultures and in living organisms
will result in various phenotype and gene expression
changes. Depending on these changes, the rough func-
tional roles of lncRNAs can be deduced. Subsequently, de-
tailed function and mechanism of the lncRNAs can be
explored by means of approaches such as fluorescence in
situ hybridization, RNA immunoprecipitation and RIP-
Chip, et cetera [26].
Conclusions
To our knowledge, this is the first study addressing lncRNA
expression profiles in IDD. Our findings shed a novel light
on our understandings of the pathogenesis of IDD. Further
studies should focus on the function and pathogenic mech-
anisms of the lncRNAs involved in IDD. Advances in the
knowledge of lncRNAs in IDD may be greatly valuable for
bench to bedside translational work to benefit patients suf-
fering from symptomatic IDD.
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